Leaflet LENALIDOMIDA ALKALOID-INT 25mg capsules
Indicated for: multiple myeloma
Route of administration: oral
Substance: lenalidomide (immunomodulator)
ATC: L04AX04 (Antineoplastic and immunomodulating agents | Immunosuppressants | Other immunosuppressants)
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
Avoid live vaccines during treatment if contraindicated.
This medicine may increase the risk of infections.
This medicine may affect fetal development.
Lenalidomide is a medication used for the treatment of multiple myeloma, myelodysplastic syndromes, and other hematologic conditions. It works by modulating the immune system and inhibiting tumor cell growth.
The medication is taken orally, usually once daily, as part of a treatment cycle prescribed by a doctor. Regular monitoring of hematologic function is important, and precautions must be taken to avoid pregnancy.
Side effects may include fatigue, anemia, neutropenia, or skin rashes. In rare cases, deep vein thrombosis or severe allergic reactions may occur.
Lenalidomide is not recommended for pregnant women or those planning to become pregnant, as well as patients with hypersensitivity to this medication.
General data about LENALIDOMIDA ALKALOID-INT 25mg
- Substance: lenalidomide
- Date of last drug list: 01-06-2026
- Commercial code: W67877002
- Concentration: 25mg
- Pharmaceutical form: capsules
- Quantity: 21
- Product type: generic
- Price: 2617.51 RON
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Concentrations available for lenalidomide
- 10mg
- 15mg
- 2.5mg
- 20mg
- 25mg
- 5mg
- 7.5mg